China seeks to become major global vaccine player in wake of Covid-19 pandemic

bd732daf-b09e-4653-bf09-212576d46241_4326e089

China is trying to reshape its pharmaceutical industry and take on an unprecedented role as a major vaccine supplier to the rest of the world in light of the ongoing Covid-19 pandemic.

It aims to produce enough doses to vaccinate 70 per cent of the country’s population, or 980 million people, and the same amount for export by the end of the year, according to Feng Duojia, president of China Association for Vaccines.